文献速递儿童青少年精神

全球自闭症谱系的流行病学与健康负担:2021年全球疾病负担研究结果

The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021.
PubMed 文献 · Lancet Psychiatry · 2024-12-19

该研究基于2021年全球疾病负担研究(GBD 2021),通过系统文献综述和贝叶斯元回归工具估算全球自闭症谱系障碍的患病率和健康负担。作者强调早期识别和支持的重要性,并呼吁改善全球流行病学数据的覆盖。

要点

  • 全球年龄标化患病率为每10万人788.3例,男性1064.7例、女性508.1例。
  • 自闭症谱系障碍在20岁以下人群中非致死性健康负担排名前十。

核心结论

  • 自闭症谱系障碍在20岁以下人群中患病率高且非致死性健康负担排名靠前,凸显全球范围内早期识别和支持自闭症青少年及其照护者的重要性。
  • 作者认为需要改进研究结果的精确性和全球代表性,首先应改善全球流行病学数据覆盖以更好地确定地理差异。
  • 作者指出本项工作可指导未来研究方向以及有关卫生服务分配的决策,以更好地满足所有自闭症个体的需求。

研究设计与样本

  • GBD 2021通过系统文献综述检索PubMed、Embase、PsycINFO和全球健康数据交换库,并咨询专家,识别自闭症谱系障碍的流行病学数据。
  • 使用贝叶斯元回归工具(DisMod-MR 2.1)估算患病率,并利用建模患病率和伤残权重估算伤残损失寿命年(YLDs)和伤残调整生命年(DALYs)。
  • 有自闭症亲身经历者参与了本文的设计、准备、解释和写作。

主要发现

  • 全球年龄标化患病率为每10万人788.3(663.8–927.2)例,相当于每10万名男性中1064.7(898.5–1245.7)例自闭症男性,每10万名女性中508.1(424.6–604.3)例自闭症女性。
  • 超区域层面,年龄标化DALY率从东南亚、东亚和大洋洲的每10万人126.5(86.0–178.0)DALYs到高收入超区域的每10万人204.1(140.7–284.7)DALYs。
  • DALYs在整个生命周期中均存在,5岁以下儿童为每10万人169.2(115.0–237.4)DALYs,并随年龄下降:20岁以下为每10万人163.4(110.6–229.8)DALYs,20岁及以上为每10万人137.7(93.9–194.5)DALYs。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 数据按族裔不可用。
  • 作者指出需要改进研究结果的精确性和全球代表性,首先应改善全球流行病学数据覆盖以更好地确定地理差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-quality estimates of the epidemiology of the autism spectrum and the health needs of autistic people are necessary for service planners and resource allocators. Here we present the global prevalence and health burden of autism spectrum disorder from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 following improvements to the epidemiological data and burden estimation methods. METHODS: For GBD 2021, a systematic literature review involving searches in PubMed, Embase, PsycINFO, the Global Health Data Exchange, and consultation with experts identified data on the epidemiology of autism spectrum disorder. Eligible data were used to estimate prevalence via a Bayesian meta-regression tool (DisMod-MR 2.1). Modelled prevalence and disability weights were used to estimate health burden in years lived with disability (YLDs) as the measure of non-fatal health burden and disability-adjusted life-years (DALYs) as the measure of overall health burden. Data by ethnicity were not available. People with lived experience of autism were involved in the design, preparation, interpretation, and writing of this Article. FINDINGS: An estimated 61·8 million (95% uncertainty interval 52·1-72·7) individuals (one in every 127 people) were on the autism spectrum globally in 2021. The global age-standardised prevalence was 788·3 (663·8-927·2) per 100 000 people, equivalent to 1064·7 (898·5-1245·7) autistic males per 100 000 males and 508·1 (424·6-604·3) autistic females per 100 000 females. Autism spectrum disorder accounted for 11·5 million (7·8-16·3) DALYs, equivalent to 147·6 (100·2-208·2) DALYs per 100 000 people (age-standardised) globally. At the super-region level, age-standardised DALY rates ranged from 126·5 (86·0-178·0) per 100 000 people in southeast Asia, east Asia, and Oceania to 204·1 (140·7-284·7) per 100 000 people in the high-income super-region. DALYs were evident across the lifespan, emerging for children younger than age 5 years (169·2 [115·0-237·4] DALYs per 100 000 people) and decreasing with age (163·4 [110·6-229·8] DALYs per 100 000 people younger than 20 years and 137·7 [93·9-194·5] DALYs per 100 000 people aged 20 years and older). Autism spectrum disorder was ranked within the top-ten causes of non-fatal health burden for people younger than 20 years. INTERPRETATION: The high prevalence and high rank for non-fatal health burden of autism spectrum disorder in people younger than 20 years underscore the importance of early detection and support to autistic young people and their caregivers globally. Work to improve the precision and global representation of our findings is required, starting with better global coverage of epidemiological data so that geographical variations can be better ascertained. The work presented here can guide future research efforts, and importantly, decisions concerning allocation of health services that better address the needs of all autistic individuals. FUNDING: Queensland Health and the Bill & Melinda Gates Foundation.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021. Lancet Psychiatry. 2024. PMID: 39709974. doi:10.1016/S2215-0366(24)00363-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。